PDS Biotechnology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $59 | $0 |
Gross Profit | -15 | -15 | 29 | -15 |
EBITDA | -7,289 | -8,722 | -6,842 | -9,496 |
EBIT | -7,295 | -8,727 | -6,857 | -9,511 |
Net Income | -9,434 | -8,489 | -7,952 | -10,727 |
Net Change In Cash | 0 | 0 | 59 | 0 |
Free Cash Flow | -9,101 | -9,032 | -8,234 | -8,000 |
Cash | 31,873 | 39,978 | 41,689 | 49,751 |
Basic Shares | 45,902 | 40,521 | 36,453 | 36,807 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -59 | -57 | -49 | -246 |
EBITDA | -33,747 | -40,085 | -40,688 | -21,189 |
EBIT | -33,806 | -40,142 | -40,737 | -21,435 |
Net Income | -37,610 | -42,942 | -40,855 | -16,918 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 8,577 | |||
Free Cash Flow | -35,059 | -33,636 | -25,710 | -12,486 |
Cash | 41,689 | 56,560 | 73,820 | 65,242 |
Basic Shares | 36,453 | 30,952 | 28,599 | 25,597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.21 |
2024-12-31 | -$0.21 |
